Traws Pharma
(NASDAQ) ONTX
Traws Pharma Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$387.30K
Net Income (TTM)
$3.95B
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ONTX News
ONTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Traws Pharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
7
CEO
Iain David Dukes, PhD
Website
www.trawspharma.comHeadquarters
Newtown, PA 18940, US
ONTX Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-4%
Net Income Margin
-3%
Return on Equity
78%
Return on Capital
-1%
Return on Assets
-58%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$142.37M
EBITDA
$142.37M
Operating Cash Flow
$2.98M
Capital Expenditure
$0.00
Free Cash Flow
$2.98M
Cash & ST Invst.
$21.34M
Total Debt
$0.00
Traws Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
16
N/A
Net Income
$3.96B
-46649.3%
EBITDA
$3.95B
-46139.5%
Quarterly Fundamentals
Net Cash
$6.42B
+118569.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-58.25%
N/A
Return on Invested Capital
-1.18%
N/A
Free Cash Flow
$15.42B
-110344.5%
Operating Cash Flow
$15.42B
-91127.3%